Page 6 - Manip Nestor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Manip nestor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Manip Nestor Today - Breaking & Trending Today

9,330 Shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Acquired by Mach 1 Financial Group LLC

Mach 1 Financial Group LLC acquired a new position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 9,330 shares of the specialty pharmaceutical company’s stock, valued at approximately $502,000. Mach 1 Financial Group LLC […] ....

United States , Antonior Pera , Pharmaceuticals Daily , Financial Services Group Inc , Oregon Public Employees Retirement Fund , Exchange Commission , Pharmaceuticals Inc , American International Group Inc , Securities Exchange Commission , Financial Group , Pharmaceuticals Company Profile , Pharmaceuticals Price Performance , Ensign Peak Advisors Inc , Charles Schwab Investment Management Inc , Free Report , Public Employees Retirement Fund , Schwab Investment Management , International Group , Peak Advisors Inc , Services Group , Director Antonio , Get Free Report , Visit Holdingschannel , Ani Pharmaceuticals , Nasdaq Anip , Sec Filings ,

ANI Pharmaceuticals (NASDAQ:ANIP) Releases FY 2023 Earnings Guidance

ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) updated its FY 2023 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $3.62-$4.11 for the period, compared to the consensus estimate of $3.97. The company issued revenue guidance of $425.00 million-$445.00 million, compared to the consensus revenue estimate of $442.97 million. Analysts Set […] ....

United States , Pharmaceuticals Stock Performance , Financial Services Group Inc , Pharmaceuticals Inc , Swiss National Bank , Metlife Investment Management , Pharmaceuticals Daily , Citigroup Inc , Ani Pharmaceuticals , Get Free Report , Moderate Buy , National Bank , Services Group , Life Investment Management , Rhumbline Advisers , Nasdaq Anip ,

BTC Capital Management Inc. Acquires 693 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

BTC Capital Management Inc. grew its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 10.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,337 shares of the specialty pharmaceutical company’s stock after purchasing an additional 693 shares during the […] ....

United States , Muthusamy Shanmugam , Zurcher Kantonalbank Zurich Cantonalbank , Exchange Commission , Lazard Asset Management , Securities Exchange Commission , Pharmaceuticals Inc , Ridgewood Investments , Btc Capital Management Inc , Pharmaceuticals Daily , Pharmaceuticals Price Performance , Capital Management Inc , Free Report , Asset Management , Kantonalbank Zurich Cantonalbank , Systematic Financial Management , Get Free Report , Visit Holdingschannel , Ani Pharmaceuticals , Nasdaq Anip , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Brandywine Global Investment Management LLC Increases Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

Brandywine Global Investment Management LLC increased its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 1.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 129,853 shares of the specialty pharmaceutical company’s stock after purchasing an additional 2,185 […] ....

United States , Brandywine Global Investment Management , Pharmaceuticals Daily , Commonwealth Equity Services , Charles Schwab Investment Management Inc , Pharmaceuticals Price Performance , American International Group Inc , Pharmaceuticals Inc , Securities Exchange Commission , Financial Services Group Inc , Free Report , Global Investment Management , Schwab Investment Management , International Group , Equity Services , Services Group , Get Free Report , Exchange Commission , Ani Pharmaceuticals , Nasdaq Anip , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

ANI Pharmaceuticals (NASDAQ:ANIP) Given Buy Rating at Truist Financial

Truist Financial reissued their buy rating on shares of ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) in a research report released on Monday morning, Benzinga reports. Truist Financial currently has a $70.00 target price on the specialty pharmaceutical company’s stock. Several other brokerages have also recently weighed in on ANIP. TheStreet upgraded shares of ANI Pharmaceuticals […] ....

United States , Nova Scotia , Pharmaceuticals Price Performance , Blackrock Inc , Pharmaceuticals Inc , Pharmaceuticals Company Profile , Pharmaceuticals Daily , Securities Exchange Commission , Balyasny Asset Management , Truist Financial , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Track Capital , Capital Management , Ani Pharmaceuticals , Nasdaq Anip , Reiterated Rating , Truist Financial Co ,